We are live on !
Find out more
NF Trinity Capital Portfolio holdings
AUM
$626M
Turnover
24%
1-Year Est. Return
3.16%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$705M
AUM Growth
-$33.5M
(-4.5%)
Cap. Flow
-$127M
Cap. Flow % of AUM
Cap. Flow %
-18%
Top 10 Holdings %
Top 10 Hldgs %
65.12%
Holding
53
New
9
Increased
1
Reduced
9
Closed
5
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
1.1
years
Top 20 Avg Time Held
Equity + Options
1.2
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Pharmaceuticals
ACAD
|
+$6.11M |
| 2 |
NXP Semiconductors
NXPI
|
+$4.99M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$4.8M |
| 4 |
TAL Education Group
TAL
|
+$4M |
| 5 |
MSCC
Microsemi Corp
MSCC
|
+$3.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$13.6M |
| 2 |
Baidu
BIDU
|
+$8.3M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$6.49M |
| 4 |
Meta Platforms (Facebook)
META
|
+$6.02M |
| 5 |
Apple
AAPL
|
+$5.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 26.21% |
| 2 | Miscellaneous | 21.18% |
| 3 | Consumer Discretionary | 15.73% |
| 4 | Healthcare | 12.78% |
| 5 | Technology | 11.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Alibaba
BABA
$248B
| $99.2M | 14.07% |
704,382
| – | – |
2015 Q4
6 quarters
|
|
2
Bank of America
BAC
$354B
| $58.2M | 8.24% |
2,396,982
-220,000
| -8% | -$5.13M |
2015 Q4
6 quarters
|
|
|
3
Apple
AAPL
$5.07T
| $49.2M | 6.97% |
1,365,588
-160,000
| -10% | -$5.92M |
2015 Q4
6 quarters
|
|
|
4
Alphabet (Google) Class A
GOOGL
$3.92T
| $47.8M | 6.77% |
1,028,000
-138,800
| -12% | -$6.49M |
2015 Q4
6 quarters
|
|
5
Walt Disney
DIS
$194B
| $41.8M | 5.92% |
393,230
| – | – |
2015 Q4
6 quarters
|
|
|
6
Baidu
BIDU
$26.3B
| $39.5M | 5.59% |
220,657
-45,813
| -17% | -$8.3M |
2015 Q4
6 quarters
|
|
|
7
Meta Platforms (Facebook)
META
$1.64T
| $38.8M | 5.51% |
257,300
-40,500
| -14% | -$6.02M |
2015 Q4
6 quarters
|
|
|
8
iShares Biotechnology ETF
IBB
$10.8B
| $26.8M | 3.8% |
259,050
-138,000
| -35% | -$13.6M |
2015 Q4
6 quarters
|
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $23.3M | 3.3% |
95,648
-12,500
| -12% | -$2.94M |
2015 Q4
6 quarters
|
|
10
State Street Health Care Select Sector SPDR ETF
XLV
$46.6B
| $23M | 3.26% |
290,100
| – | – |
2015 Q4
6 quarters
|
|
11
State Street Energy Select Sector SPDR ETF
XLE
$45.4B
| $16.3M | 2.31% |
502,560
| – | – |
2015 Q4
6 quarters
|
|
12
Universal Display
OLED
$4B
| $11.8M | 1.67% |
107,889
| – | – |
2016 Q3
3 quarters
|
|
13
JD.com
JD
$34.2B
| $11.2M | 1.59% |
286,335
-114,389
| -29% | -$4.32M |
2016 Q1
5 quarters
|
|
14
Bristol-Myers Squibb
BMY
$126B
| $10.4M | 1.47% |
186,000
| – | – |
2015 Q4
6 quarters
|
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $9.21M | 1.31% |
70,917
| – | – |
2015 Q4
6 quarters
|
|
16
Mastercard
MA
$546B
| $8.43M | 1.19% |
69,400
| – | – |
2015 Q4
6 quarters
|
|
17
Lockheed Martin
LMT
$139B
| $8.33M | 1.18% |
30,000
| – | – |
2016 Q1
5 quarters
|
|
18
BioMarin Pharmaceuticals
BMRN
$10.8B
| $8.16M | 1.16% |
89,900
+34,000
| +61% | +$3.09M |
2017 Q1
1 quarter
|
|
19
Liberty Global Class A
LBTYA
$2.68B
| $7.62M | 1.08% |
237,371
| – | – |
2015 Q4
6 quarters
|
|
20
Citigroup
C
$202B
| $6.82M | 0.97% |
101,930
| – | – |
2015 Q4
6 quarters
|
|
21
Biogen
BIIB
$37B
| $6.51M | 0.92% |
24,000
| – | – |
2015 Q4
6 quarters
|
|
22
Gilead Sciences
GILD
$193B
| $6.16M | 0.87% |
86,959
| – | – |
2015 Q4
6 quarters
|
|
|
23
Acadia Pharmaceuticals
ACAD
$3.4B
| $5.72M | 0.81% |
+205,000
| New | +$6.11M |
2017 Q2
0 quarters
|
|
|
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.6M | 0.79% |
46,000
| – | – |
2016 Q3
3 quarters
|
|
|
25
NXP Semiconductors
NXPI
$59.2B
| $5.1M | 0.72% |
+46,600
| New | +$4.99M |
2017 Q2
0 quarters
|
|
Similar funds
SHCM
IAS
NF Trinity Capital's Q2 2017 Portfolio in Review
As of Q2 2017, NF Trinity Capital held 53 positions worth $705M, down 4.5% from $739M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
NF Trinity Capital withdrew a net $127M in Q2 2017, closing 5 positions and reducing 9 holdings. Its most notable exit was PayPal, an estimated $5.42M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
Against the trend, NF Trinity Capital opened a new position in Acadia Pharmaceuticals worth $5.72M.
- NF Trinity Capital's largest Q2 2017 buy was Acadia Pharmaceuticals: 205,000 shares worth $5.72M.
- NF Trinity Capital added most to BioMarin Pharmaceuticals in Q2 2017, an estimated $3.09M increase.
- NF Trinity Capital's biggest Q2 2017 reduction was iShares Biotechnology ETF, cutting an estimated $13.6M.
- NF Trinity Capital fully exited PayPal in Q2 2017, selling an estimated $5.42M.
- NF Trinity Capital's ten largest holdings make up 65% of its $705M portfolio in Q2 2017.
- NF Trinity Capital opened 9 new positions and closed 5 in Q2 2017.
- NF Trinity Capital's portfolio value fell 4.5% quarter-over-quarter to $705M.
Based on NF Trinity Capital's 13F filing for Q2 2017, filed 8 Aug 2017.